This fund aims to deliver three times the daily inverse performance of a biotechnology industry index, meaning it is designed to gain when that index falls and lose when it rises. To achieve this, the fund puts at least 80% of its assets into financial instruments such as swaps, futures, and short positions. Investors should be aware that this is a concentrated, high-risk product focused solely on the biotechnology sector.
